ARCHIVES

R.S.K. Young Quits As FDA Oncology Group Leader

This article is from The Cancer Letter archive.

Vol. 06 No. 28 | July 11, 1980

Download PDF Visit The Full Archive

Related Articles

Human Protein Index Stirs NCI, NCAB Interest, Fires Up Growing Controversy

August 7, 1981

Van Etten To Take Over As Director Of UC Irvine Chao Cancer Center

July 25, 2013

Clinical Center Director Plans Revitalization of Research Training

December 9, 1994

Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation

April 28, 2006

Biomarker Test Outperforms PSA and Gleason Score in Study

July 26, 2013

NCCS Networker Volume 8 Issue 2, Summer 1994

June 13, 1994